Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06233383
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-01-22
Brief Title:
Developing Screening Clinical Breast Examination Implementation Strategies in South Africa
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Developing an Approach to Implementing Breast Cancer Screening Using Clinical Breast Exam in the Primary Health Centers of Soweto South Africa
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to engage with multilevel stakeholders to collaboratively and to systematically develop a suite of strategies for implementing breast cancer screening using clinical breast examination CBE in the primary health centers within the catchment area of Chris Hani Baragwanath Academic Hospital Bara Hospital Johannesburg South Africa
The main questions it aims to answer are What barriers and facilitators exist to conducting screening CBE in Sowetos primary care setting and what implementation strategies would support CBE in primary care clinics
Participants will
Allow observation of study clinic workflows
Participate in focus group discussions regarding screening CBE implementation
The main questions it aims to answer are What barriers and facilitators exist to conducting screening CBE in Sowetos primary care setting and what implementation strategies would support CBE in primary care clinics
Participants will
Allow observation of study clinic workflows
Participate in focus group discussions regarding screening CBE implementation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None